Dr Gregory Walker
PhD (Virology), 2022, University of New South Wales
B Biomedical Science (Hons), 2015, University of Newcastle
I am an early career researcher and virologist based at the Virology Research Laboratory (Prince of Wales Hospital Randwick), University of New South Wales. My areas of expertise include 1) viral detection and diagnostics, 2) genomic surveillance of viral epidemics, and 3) characterization of antibody-mediated immunity to viral infections. I have experience in whole genome sequencing of respiratory viruses (RSV, Influenzavirus and SARS-CoV-2), serological techniques for viral detection and characterisation, and culturing of clinical virus isolates (including highly infectious variants of SARS-CoV-2 under PC3 conditions). I am also an Associate Investigator within the Virology theme of the Environmental Determinants of Islet Autoimmunity (ENDIA) Study, following 1,500 mother-infant pairs with a first-degree relative with type 1 diabetes across Australia (https://endia.org.au).
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
NHMRC Investigator (EL1), 2024-2028. CIA, $662,040.
Characterising viruses that promote the development of type 1 diabetes. NHMRC European Partnership, 2024-2027. CID (CIA-Kim), $499,999
Epidemiology of Respiratory Syncytial Virus and other respiratory viruses. GSK Supported Study, 2023-2025. CIA, $95,654
Viral genetic determinants of respiratory syncytial virus (RSV) underlying clinical disease severity in pediatric infection. Thrasher Research Fund, 2023. CIA, US$25,000.
My Research Supervision
1x PhD student (School of Biomedical Sciences), 2022-2024, Genomic characterisation of influenza viruses
1x Honours student (School of Biomedical Sciences), 2024, Wastewater surveillance of respiratory viruses
2025: 1x Honours student committed